<?xml version='1.0' encoding='utf-8'?>
<document id="22645493"><sentence text="Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats."><entity charOffset="49-60" id="DDI-PubMed.22645493.s1.e0" text="simvastatin" /><entity charOffset="66-76" id="DDI-PubMed.22645493.s1.e1" text="ivabradine" /><pair ddi="false" e1="DDI-PubMed.22645493.s1.e0" e2="DDI-PubMed.22645493.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22645493.s1.e0" e2="DDI-PubMed.22645493.s1.e1" /></sentence><sentence text="Ivabradine is a novel heart rate lowering agent that inhibits I(f) ionic current in the sinus node and demonstrates antiischaemic and antianginal activity"><entity charOffset="0-10" id="DDI-PubMed.22645493.s2.e0" text="Ivabradine" /></sentence><sentence text=" The aim of the paper was to investigate the effect its dose-dependent drug-drug interaction with simvastatin inhibitor HMGCo-A has on PAI-1 blood level, heart rate and blood pressure"><entity charOffset="98-109" id="DDI-PubMed.22645493.s3.e0" text="simvastatin" /></sentence><sentence text=" The experiments were performed in hyper- and normocholesterolemic Wistar rats receiving simvastatin (1 and 20 mg × kg(-1) bw) with ivabradine (10 mg × kg(-1) bw) during a 4-week period"><entity charOffset="89-100" id="DDI-PubMed.22645493.s4.e0" text="simvastatin" /><entity charOffset="132-142" id="DDI-PubMed.22645493.s4.e1" text="ivabradine" /><pair ddi="false" e1="DDI-PubMed.22645493.s4.e0" e2="DDI-PubMed.22645493.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22645493.s4.e0" e2="DDI-PubMed.22645493.s4.e1" /></sentence><sentence text=" Ivabradine exacerbated the decrease of PAI-1 in normocholesterolemic animals receiving simvastatin at a dose of 1 mg/kg bw and was not observed to have any significant influence on the PAI-1 values in rats receiving 20 mg × kg(-1) bw simvastatin"><entity charOffset="1-11" id="DDI-PubMed.22645493.s5.e0" text="Ivabradine" /><entity charOffset="88-99" id="DDI-PubMed.22645493.s5.e1" text="simvastatin" /><entity charOffset="235-246" id="DDI-PubMed.22645493.s5.e2" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.22645493.s5.e0" e2="DDI-PubMed.22645493.s5.e0" /><pair ddi="false" e1="DDI-PubMed.22645493.s5.e0" e2="DDI-PubMed.22645493.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22645493.s5.e0" e2="DDI-PubMed.22645493.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22645493.s5.e1" e2="DDI-PubMed.22645493.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22645493.s5.e1" e2="DDI-PubMed.22645493.s5.e2" /></sentence><sentence text=" Ivabradine, coadministered with simvastatin given at a dose of 20 mg × kg(-1) bw, significantly slowed the heart rate in normocholesterolaemic and hypercholesterolaemic groups as compared to the group receiving ivabradine alone"><entity charOffset="1-11" id="DDI-PubMed.22645493.s6.e0" text="Ivabradine" /><entity charOffset="33-44" id="DDI-PubMed.22645493.s6.e1" text="simvastatin" /><entity charOffset="212-222" id="DDI-PubMed.22645493.s6.e2" text="ivabradine" /><pair ddi="false" e1="DDI-PubMed.22645493.s6.e0" e2="DDI-PubMed.22645493.s6.e0" /><pair ddi="false" e1="DDI-PubMed.22645493.s6.e0" e2="DDI-PubMed.22645493.s6.e1" /><pair ddi="false" e1="DDI-PubMed.22645493.s6.e0" e2="DDI-PubMed.22645493.s6.e2" /><pair ddi="false" e1="DDI-PubMed.22645493.s6.e1" e2="DDI-PubMed.22645493.s6.e1" /><pair ddi="false" e1="DDI-PubMed.22645493.s6.e1" e2="DDI-PubMed.22645493.s6.e2" /></sentence><sentence text=" Conclusion" /><sentence text=" The administration of ivabradine to normocholesterolaemic and hypercholesterolaemic rats receiving simvastatin significantly exacerbated the slowing of heart rate with no effect on blood pressure"><entity charOffset="23-33" id="DDI-PubMed.22645493.s8.e0" text="ivabradine" /><entity charOffset="100-111" id="DDI-PubMed.22645493.s8.e1" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.22645493.s8.e0" e2="DDI-PubMed.22645493.s8.e0" /><pair ddi="false" e1="DDI-PubMed.22645493.s8.e0" e2="DDI-PubMed.22645493.s8.e1" /></sentence><sentence text=" The administration of ivabradine has been shown to demonstrate different effects on PAI-1 values depending on lipid disorders"><entity charOffset="23-33" id="DDI-PubMed.22645493.s9.e0" text="ivabradine" /></sentence><sentence text="" /></document>